LORENZO, R. B.; LORENZO, L. S.; GONZÁLEZ-MARTÍN, A. Will the carboplatin-paclitaxel-bevacizumab combination become the preferred option as the first line in advanced cervical cancer? A small experience from a single oncologic Center:  . Cancer Breaking News, [S. l.], v. 5, n. 1, p. 21–24, 2017. DOI: 10.19156/cbn.2017.0035. Disponível em: https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/171. Acesso em: 22 nov. 2024.